Cargando…
Purdue MP, Hofmann JN, Kemp TJ, et al. A prospective study of 67 serum immune and inflammation markers and risk of non–Hodgkin lymphoma. Blood. 2013;122(6):951-957.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Society of Hematology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007617/ http://dx.doi.org/10.1182/blood-2014-03-563767 |
Ejemplares similares
-
Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
Publicado: (2014) -
Lavender KJ, Pang WW, Messer RJ, et al. BLT-humanized C57BL/6 Rag2(−/−)γ(c)(−/−)CD47(–/–) mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood. 2013;122(25):4013-4020.
Publicado: (2014) -
Nicol MP et al (Clin Infect Dis 2013; 57:e18–21)
Publicado: (2014) -
EOS deployment at Purdue
por: Piperov, Stefan
Publicado: (2022) -
John Purdue Gray
Publicado: (1887)